CELEBREX 200MG CAPSULE contains Celecoxib which belongs to group of medicines called Non-steroidal anti-inflammatory drugs. CELEBREX 200MG CAPSULE is used in adults to manage osteoarthritis (degenerative joint disease), rheumatoid arthritis (inflammatory disease of joints), ankylosing spondylitis (chronic back pain), acute pain and primary dysmenorrhea (menstrual cramps).
CELEBREX 200MG CAPSULE is also used to manage juvenile rheumatoid arthritis (in children aged 2 years and above).
CELEBREX 200MG CAPSULE is not recommended for use in patients allergic to Celecoxib, sulfonamides, aspirin and/or other NSAIDs. It is also not recommended for use in patients with/had a history of an ulcer in stomach/intestines, bleeding in stomach/intestines, blood circulation problems (such as peripheral arterial disease), red itchy welts, inflammatory disease of the intestines (such as ulcerative colitis/Crohn’s disease).
The medicine is also not indicted for use in patients suffering from lung problems (such as asthma), heart diseases (such as heart failure, recent heart attack, heart block), severe liver disease (such as advanced hepatic insufficiency) and/or kidney disease (such as advanced renal insufficiency).
Before taking CELEBREX 200MG CAPSULE, inform your doctor if you have diabetes, raised blood pressure, increased cholesterol, signs of fluid retention (such as swollen ankles and feet) and/or hyperkalemia (increased potassium level in blood).
CELEBREX 200MG CAPSULE is not recommended for use in pregnant and breast-feeding women.
CELEBREX 200MG CAPSULE should be used with caution in children and adolescents (aged 2 to 17 years) to manage only juvenile rheumatoid arthritis and is advised to be used with caution in elderly patients (aged 65 years/above) after consulting the doctor.
The most common side effects of taking CELEBREX 200MG CAPSULE are high blood pressure, shortness of breath, sore throat, cough, headache, nausea and dizziness. Consult your doctor if any of these symptoms worsen.
As part of dosage and/or TABLET treatment may have to be stopped and/or reversed after your doctor decides. Tell your doctor if you have an allergy to CELEBREX 200MG CAPSULE or if you are allergic to any other anti-inflammatory medicine such as aspirin, other NSAIDs, etc. Fill out the form for free.How long does it take for CELEBREX 200MG CAPSULE to take effectCELEBREX 200MG CAPSULE should work within 24 hours.aird pain and onset of action, diarrhea, difficulty in passing urine, headache, feeling sick, tirednessrienoingestions lasts longer than 10 hours.
How long it takesThe medicine works by reducing the production of prostaglandins which are important components of the body. Symptoms of low blood pressure include dizziness, lightheadedness, dizziness, fainting, blurred vision, and muscle pain. Consult your doctor if this doesn’t help your pain or if you experience any side effects.
How long you take CELEBREX 200MG CAPSULE varies between patients, but it is advised to take it exactly as prescribed by your doctor. It is crucial you do not stop taking CELEBREX 200MG CAPSULE without consulting your doctor.
The course of treatment is one to one and week to full recovery. Please note that CELEBREX 200MG CAPSULE may interact with other medicines and cause severe reactions including kidney failure, liver damage, and any kidney problems. Inform your doctor if you are sick, debilitated, pregnant or breastfeeding and mention if you are allergic to Celecoxib, aspirin, NSAIDs, blood thinners, kidney or liver disease, kidney problems or other anti-inflammatory medicines. It’s best to take CELEBREX 200MG CAPSULE with caution in patients with severe heart failure.
Oral tablets may be taken with or without food.
How should I take CELEBREX 200MG CAPSULE?AstraZeneca has been fined $2.5 million for failing to warn consumers that its cholesterol drug Celebrex may increase the risk of heart attack and stroke. The company has also agreed to pay $750 million to settle claims by consumers that the drug increases the risk of heart attacks and strokes by more than twice the amount of the drug, which is known as Vioxx.
The settlement comes on the heels of an agreement reached between AstraZeneca and Pfizer, the drugmaker, that Pfizer may be required to update information about the cardiovascular risks of Celebrex, but that it has not yet received the required updates.
Pfizer said that a letter from the United States Food and Drug Administration (FDA) has found that there is a risk of heart attack or stroke that would increase the risk of heart attacks or strokes by more than a two-fold, or the risk for strokes by more than the risk of heart attacks or strokes.
Celebrex, which the company called “the most popular drug on the market today,” is widely used to lower cholesterol, treat rhabdomyosarcoma, an enlarged prostate and prevent prostate cancer.
The company is also required to inform patients that it is taking a multifactorial approach to the risk, including a “risk-reducing drug,” which includes Vioxx, in patients with a history of heart attacks or strokes, and a “safe drug” that blocks COX-2 enzymes that are important in preventing cardiovascular disease.
Celebrex, which was launched in the U. S. market, had a total of approximately $12.4 billion in revenue in the year to June 2009, according to IMS Health data.
Pfizer’s decision to settle the case comes after the drugmaker was forced to admit to a price-fixing scandal over the drug’s safety.
The agreement between AstraZeneca and Pfizer, which the company said was the result of a “black-box” warning issued by the FDA in 2004, came hours after an FDA panel that considered the drugmaker’s warnings about its potential to increase the risk of heart attack and stroke.
The panel, the FDA’s drug review board, recommended the company not disclose the risks of Celebrex to patients because they were not properly warned of the potential for increased cardiovascular risks. The panel said the company had not disclosed the risks, but the FDA panel’s review said it had found no information about the drug’s effects on heart attacks or strokes.
The FDA said it was “reviewing” the matter and determining whether the drugmaker should have updated the information. It said there were no new reports of heart problems in patients taking the drug, but there were no reports of a heart attack or stroke. It said the panel’s recommendation was that the agency continue to monitor the FDA’s review, and Pfizer should return the drug to its previous management, for a change.
Pfizer said the FDA’s review did not include any information about the drug’s effects on the body’s own, such as the possibility of increased heart attacks or strokes.
AstraZeneca said that the company had not disclosed any of the risks of the drug, and it “is not clear from the evidence that the information on the risk is what is considered accurate and reliable information.”
Pfizer said that “this settlement should provide patients and consumers with a meaningful and affordable way to access this important drug.”
AstraZeneca said that it was “committed to continue to provide patients with safe, effective, affordable, and effective treatment for their cardiovascular concerns.”
The FDA said that Pfizer had not been required to update the information in the case, but it has agreed to do so, and it is expected to receive the required updates from the FDA.
AstraZeneca said that the company was taking no second option in the case and is expected to provide patients with a full and complete list of all its medications, including prescription drugs, that it has information about. The company said that the decision to settle the case was final and should be made “as soon as possible.”
For more on the case, including information about the case and case-specific lawsuits,.
This is part of a new.If you have questions about the case or.
The Associated Press contributed to this report.
Celebrex 200mg capsule contains the active ingredient Celecoxib. It belongs to the family known as non-steroidal anti-inflammatory drugs (NSAID), and specifically a sub-group known as cyclooxygenase-2 (COX-2) inhibitors. It is used in adults for the relief of signs and symptoms of rheumatoid arthritis, osteoarthritis, and ankylosing spondylitis. In conditions like rheumatoid arthritis and osteoarthritis, excess production of prostaglandins by your body can lead to pain and inflammation. This medicine works by decreasing the production of prostaglandins, effectively reducing pain and inflammation.
Do not take Celebrex 200mg capsule if you are allergic to Celecoxib or any of its ingredients. Inform your doctor if you had reactions to sulfonamide medicines, suffer from ulcers or bleeding in the stomach or intestines, or experienced adverse reactions to NSAID medications like aspirin. Before starting the treatment, inform your doctor because it is recommended to not take this medicine if you are pregnant or are breastfeeding. Do not take this medicine if you have severe liver or kidney disease, have inflammatory intestinal conditions, or have heart-related issues such as heart failure, heart disease, or circulation problems. Additionally, if you have had surgeries on leg arteries or have a history of blood circulation problems, this medicine usage should be avoided. This contains lactose. If you are sugar intolerant, consult your doctor before using this product. This medicine is for adults only, it is not for use in children.
Inform your doctor about if you have a history of stomach or intestinal ulcers or bleeding (avoid if currently present), are on acetylsalicylic acid or antiplatelet therapies, use blood clotting or corticosteroid medications, or simultaneously use other non-acetylsalicylic NSAIDs like ibuprofen. Report your doctor if you have conditions such as smoking, diabetes, high blood pressure, high cholesterol, compromised heart, liver, or kidney function, fluid retention, dehydration, past severe allergic reactions to medications, ongoing infections, or are over 65 years old. Monitoring may be necessary. Notably, Celebrex 200mg capsule could mask fever or infection signs. Remember, alcohol combined with NSAIDs may increase gastrointestinal risks.
Celebrex 200mg capsule packaging for saleCelebrex 200mg Capsule 10s offers several benefits. Some of them include: • Effective pain relief • Convenient dosing schedule for daily dosing • Easy-to-swallow dosage form • Easy to swallow for children (see below). • Highly recommend for children under 18 years of age who are at risk for kidney problems or a history of bleeding or bruising • Discreet and discreet packaging. • Easy to swallow. • Short stomach: Effective pain relief is achieved through swallowing a tablet before eating or lying down for 1-2 hours. • Convenient dosing schedule: For daily dosing, it is recommended to take Celebrex 200mg capsules in the morning (2 hours before breakfast) or at least once per day with a meal. • Convenient timing: For children under 18 years of age, it is recommended to take Celebrex in the middle of the day (between 2 and 3 hours before breakfast). • Discreet and discreet packaging. • Convenient dosing schedule: For children under 18 years of age, it is recommended to take Celebrex in the middle of the day (between 2 and 3 hours before breakfast) or at least once per day. • Convenient dosing schedule: For children under 18 years of age, it is recommended to take Celebrex in the middle of the day (between 2 and 3 hours before breakfast).
Some of them include: • Effective pain relief • Convenient dosing schedule: For children under 18 years of age, it is recommended to take Celebrex 200mg capsules in the morning (2 hours before breakfast) or at least once per day. • Easy-to- swallow.